0
0

Chapter 9. Substance-Related Disorders

Martin H. Leamon, M.D.; Tara M. Wright, M.D.; Hugh Myrick, M.D.
DOI: 10.1176/appi.books.9781585623402.327735

Sections

Excerpt

Psychoactive substance use has been part of people's lives for millennia (Austin 1978). About half of the world population uses at least one psychoactive substance, and although most do so without difficulties, for others problems arise that are related to the substance use (United Nations Office on Drugs and Crime 2005). Worldwide, drug and alcohol use disorders (excluding tobacco) are the sixth leading cause of disease burden in adults, whereas tobacco use and exposure to tobacco smoke are the leading preventable causes of death (World Health Organization 2003). Nationally (again excluding tobacco), 63% of American adults report that alcohol or drug addiction in themselves, family, or close friends has had an impact on their lives (Peter D. Hart Research Associates 2004). This chapter presents an overview of substance-related disorders, primarily focusing on those substances that are abused for their psychoactive effects, with additional material contained in the "Suggested Readings" listed at the end of the chapter.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
For which of the following classes of substances does DSM-IV-TR (American Psychiatric Association 2000) recognize only the diagnoses of dependence and withdrawal?
2.
In the 2004 National Survey on Drug Use and Health, which of the following substances was associated with the highest percentage of past-year users meeting criteria for abuse or dependence?
3.
The Stages of Change model (Prochaska and DiClemente 1992) is useful for conceptualizing a patient's motivation to address substance use problems. The model divides the recovery process into sequential stages, requiring achievement of stage-specific goals before progression. Which stage has as its task determination of the best course of action?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 17.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 18.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 19.  >
DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders > Chapter 4.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 17.  >
Topic Collections
Psychiatric News
PubMed Articles
Hepatotoxicity with combination of vemurafenib and ipilimumab.
The New England journal of medicine 2013 Apr 4
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation